Finally, 5% of cases showed MYC amplification although, reportedly, none showed actual evidence of Myc over-expression despite this often being associated with shorter survivals in a variety of B-cell neoplasms, including CLL (Figure 3) [77,310,311,312,313]. This evidence concerns the gene MYC and B-cell neoplasm.